| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gabrielle Crépeau-Gendron, Sophie L'Heureu. Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report. Early intervention in psychiatry. vol 9. issue 2. 2015-12-07. PMID:24690066. |
quetiapine xr-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? |
2015-12-07 |
2023-08-12 |
Not clear |
| Z Whitney, R M Procyshyn, D H Fredrikson, A M Bar. Treatment of clozapine-associated weight gain: a systematic review. European journal of clinical pharmacology. vol 71. issue 4. 2015-11-30. PMID:25627831. |
clozapine is an antipsychotic drug with superior efficacy in treatment-resistant schizophrenia. |
2015-11-30 |
2023-08-13 |
Not clear |
| François R Girardin, Antoine Poncet, Marc Blondon, Victoria Rollason, Nathalie Vernaz, Yves Chalandon, Pierre Dayer, Christophe Combescur. Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. The lancet. Psychiatry. vol 1. issue 1. 2015-11-26. PMID:26360402. |
monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. |
2015-11-26 |
2023-08-13 |
Not clear |
| François R Girardin, Antoine Poncet, Marc Blondon, Victoria Rollason, Nathalie Vernaz, Yves Chalandon, Pierre Dayer, Christophe Combescur. Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. The lancet. Psychiatry. vol 1. issue 1. 2015-11-26. PMID:26360402. |
we aimed to assess the cost-effectiveness of various strategies to monitor white blood cell count in adult patients with schizophrenia taking clozapine. |
2015-11-26 |
2023-08-13 |
Not clear |
| Andrew M Williams, Susie H Par. Seizure associated with clozapine: incidence, etiology, and management. CNS drugs. vol 29. issue 2. 2015-11-17. PMID:25537107. |
given clozapine's strong evidence for efficacy in the treatment of schizophrenia and schizoaffective disorder, every attempt to manage side effects, including seizure, should be implemented to allow for therapeutic continuation. |
2015-11-17 |
2023-08-13 |
Not clear |
| Mei-Ling Hou, Chi-Hung Lin, Lie-Chwen Lin, Tung-Hu Tsa. The Drug-Drug Effects of Rhein on the Pharmacokinetics and Pharmacodynamics of Clozapine in Rat Brain Extracellular Fluid by In Vivo Microdialysis. The Journal of pharmacology and experimental therapeutics. vol 355. issue 1. 2015-11-17. PMID:26220937. |
clozapine, an atypical antipsychotic agent, is highly effective in treatment-resistant schizophrenia; however, its major side effect is constipation. |
2015-11-17 |
2023-08-13 |
rat |
| S A J de With, S L Pulit, T Wang, W G Staal, W W van Solinge, P I W de Bakker, R A Ophof. Genome-wide association study of lymphoblast cell viability after clozapine exposure. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 168B. issue 2. 2015-11-16. PMID:25656473. |
clozapine is an antipsychotic drug with proven efficacy in treatment-resistant schizophrenia but also known to induce potentially lethal agranulocytosis (cia) in 1% of patients. |
2015-11-16 |
2023-08-13 |
Not clear |
| Heather Gage, Hannah Family, Fenella Murphy, Peter Williams, Jane Sutton, Denise Taylo. Comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. Journal of advanced nursing. vol 71. issue 3. 2015-11-10. PMID:25376164. |
comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. |
2015-11-10 |
2023-08-13 |
Not clear |
| Heather Gage, Hannah Family, Fenella Murphy, Peter Williams, Jane Sutton, Denise Taylo. Comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. Journal of advanced nursing. vol 71. issue 3. 2015-11-10. PMID:25376164. |
to compare sole nurse and doctor-led multidisciplinary team delivery of community clozapine services for people with treatment-resistant schizophrenia. |
2015-11-10 |
2023-08-13 |
Not clear |
| Mei Han, Xiang Yang Zhang, Da Chun Chen, Yun Long Tan, Chong Sheng Song, Ying Hua Yu, Xu Feng Huan. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics. International clinical psychopharmacology. vol 30. issue 2. 2015-11-06. PMID:25568968. |
cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics. |
2015-11-06 |
2023-08-13 |
Not clear |
| Mei Han, Xiang Yang Zhang, Da Chun Chen, Yun Long Tan, Chong Sheng Song, Ying Hua Yu, Xu Feng Huan. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics. International clinical psychopharmacology. vol 30. issue 2. 2015-11-06. PMID:25568968. |
cognitive function was assessed in 418 patients with schizophrenia on long-term treatment with apds (215 on clozapine, 91 on risperidone and 112 on typical apds) and 159 healthy controls using the repeatable battery for the assessment of neuropsychological status (rbans). |
2015-11-06 |
2023-08-13 |
Not clear |
| Thomas E Winkler, Hadar Ben-Yoav, Sheryl E Chocron, Eunkyoung Kim, Deanna L Kelly, Gregory F Payne, Reza Ghodss. Electrochemical study of the catechol-modified chitosan system for clozapine treatment monitoring. Langmuir : the ACS journal of surfaces and colloids. vol 30. issue 48. 2015-10-26. PMID:25383917. |
such point-of-care monitoring will allow for broader use of clozapine by increasing convenience to patients as well as medical professionals, thus improving the lives of people affected by schizophrenia through personalized medicine. |
2015-10-26 |
2023-08-13 |
Not clear |
| Dawn I Velligan, Cathy Carroll, Maureen J Lage, Kathleen Fairma. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations. Psychiatric services (Washington, D.C.). vol 66. issue 2. 2015-10-21. PMID:25321616. |
outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations. |
2015-10-21 |
2023-08-13 |
Not clear |
| Dawn I Velligan, Cathy Carroll, Maureen J Lage, Kathleen Fairma. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations. Psychiatric services (Washington, D.C.). vol 66. issue 2. 2015-10-21. PMID:25321616. |
patients with treatment-resistant schizophrenia commonly receive nonrecommended drug regimens, including antipsychotic polypharmacy, sometimes in lieu of clozapine. |
2015-10-21 |
2023-08-13 |
Not clear |
| Marilena Gilca, Gabriela Piriu, Laura Gaman, Corina Delia, Liviu Iosif, Valeriu Atanasiu, Irina Stoia. A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics. Psychopharmacology. vol 231. issue 24. 2015-10-13. PMID:24871701. |
the aims of this study were to investigate the antioxidative activity of paraoxonase and assess lipid profile as a cardiovascular risk factor in patients with schizophrenia under long-term clozapine or risperidone treatment. |
2015-10-13 |
2023-08-13 |
Not clear |
| Shi Hyun Kang, Hye Ree Han, Jong-il Lee, Rakesh Karmacharya, Hong Jin Jeon, Sungwon Ro. Effects of LEP, LEPR, ADIPOQ, MC4R and FTO polymorphisms on dyslipidemia in Korean patients with schizophrenia who are taking clozapine. Psychiatry research. vol 228. issue 1. 2015-10-08. PMID:25841316. |
effects of lep, lepr, adipoq, mc4r and fto polymorphisms on dyslipidemia in korean patients with schizophrenia who are taking clozapine. |
2015-10-08 |
2023-08-13 |
Not clear |
| G C Smith, H McEwen, J D Steinberg, P R Shepher. The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect. Psychopharmacology. vol 231. issue 23. 2015-10-07. PMID:24800899. |
the second generation antipsychotic drug clozapine is a much more effective therapy for schizophrenia than first generation compounds, but the reasons for this are poorly understood. |
2015-10-07 |
2023-08-13 |
rat |
| Adam Wysokiński, Iwona Kłoszewsk. Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy. Psychiatry research. vol 220. issue 1-2. 2015-10-07. PMID:25219614. |
blood serum levels of cart peptide in patients with schizophrenia on clozapine monotherapy. |
2015-10-07 |
2023-08-13 |
human |
| Adam Wysokiński, Iwona Kłoszewsk. Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy. Psychiatry research. vol 220. issue 1-2. 2015-10-07. PMID:25219614. |
we compared fasting serum cart levels in subjects with schizophrenia on clozapine monotherapy (n=24) with sex- and age-matched healthy controls (n=24). |
2015-10-07 |
2023-08-13 |
human |
| Antonio Bruno, Rocco A Zoccali, Elisabetta Abenavoli, Gianluca Pandolfo, Giuseppe Scimeca, Edoardo Spina, Maria Rosaria Anna Muscatell. Augmentation of clozapine with agomelatine in partial-responder schizophrenia: a 16-week, open-label, uncontrolled pilot study. Journal of clinical psychopharmacology. vol 34. issue 4. 2015-09-28. PMID:24911437. |
augmentation of clozapine with agomelatine in partial-responder schizophrenia: a 16-week, open-label, uncontrolled pilot study. |
2015-09-28 |
2023-08-13 |
Not clear |